Month: March 2023

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

TREK-AD Phase 2b study of eblasakimab fully enrolled, topline data readout expected early July 2023 Phase 2 proof-of-concept trial of farudodstat in alopecia areata expected to commence in the second quarter of 2023 with topline data readout expected in the first quarter of 2024 Expected cash runway extended through at least the second quarter of 2024 with recent $20 million in financing, with potential to receive up an additional $80 millionSAN MATEO, Calif. and SINGAPORE, March 24, 2023 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the fourth quarter and full year ended December 31, 2022, and provided an update on recent corporate activities. “We...

Irwin Naturals Cannabis Products Launch Nationwide in Canada

Written by Customer Service on March 24, 2023. Posted in Public Companies.

Company announces products being available nationwide through Starseed Medicinal Medical PlatformIrwin Naturals Cannabis 25mg CBD Softgel Irwin Naturals Cannabis 25mg CBD SoftgelLOS ANGELES, March 24, 2023 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), is proud to announce the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical Group platform. CBD 25mg Softgels are just the first of five CBD and THC products that Irwin Naturals Cannabis, through its licensing agreement with Entourage Health Corp., plans to launch nationwide in Canada over the next few months. The company’s product lineup will include a range of CBD and THC products designed in a variety of formulations to suit consumers’...

Abeona Therapeutics Announces New Employee Inducement Grants

Written by Customer Service on March 24, 2023. Posted in Public Companies.

NEW YORK and CLEVELAND, March 24, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new employees who joined Abeona. On March 23, 2023, Abeona granted restricted stock equity awards to six employees as an inducement for them to accept employment, which equity awards relate to, in the aggregate, up to 131,750 restricted shares of Abeona common stock. One-quarter (1/4) of the shares subject to such restricted stock awards vesting on the first anniversary of the grant date, conditioned upon each employee’s continued employment on the vesting date(s). The inducement grants were approved by Abeona’s Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635(c)(4), and were granted as a material inducement to employment in accordance with Nasdaq Rule...

Global Crossing Airlines Announces Agreement with CubaMax for up to nine flights per week to Cuba with growth of up to 23 flights per week

Written by Customer Service on March 24, 2023. Posted in Public Companies.

MIAMI, March 24, 2023 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (JET: NEO; JET.B: NEO; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce that is has signed a long term agreement with CubaMax Travel (“CubaMax”), one of the leading OFAC approved tour operators, to initially provide air service to two (2) cities in Cuba, with nine (9) flights per week total to Havana and Santa Clara, Cuba. This is projected to grow to 23 flights per week to 5 cities in Cuba within the next six months. The contract will initially provide revenues to GlobalX of up to $12 million per year and will start April 1, 2023. Once the additional fights are added, GlobalX expects to generate revenues of over $30 million per year on this contract. “We are very pleased to be working with CubaMax, one of the largest tour operators to...

CRYPTYDE PROVIDES OPERATIONAL AND BUSINESS UPDATE ON ITS SUBSIDIARY, FOREVER 8

Written by Customer Service on March 24, 2023. Posted in Public Companies.

SAFETY HARBOR, Florida, March 24, 2023 (GLOBE NEWSWIRE) — Cryptyde, Inc. (NASDAQ: TYDE) is pleased to provide its investors a corporate update on its subsidiary, Forever 8 Fund, LLC (“Forever 8” or “F8”). The company continues to strengthen its operational and technological performance. Highlights: Technology As F8 begins to scale its customer count, it continues to invest in both its customer facing and internal portfolio and customer management technologies. During the last 6 months, F8 has rolled out proprietary features that enhance its customers’ inventory management experience. Some of these features include giving customers the ability to leverage F8’s demand forecasting algorithms to optimize their inventory levels and streamline the purchase order process. At the same time, F8 also provides tracking of supply chain data...

Marathon Gold Announces 2022 Fourth Quarter and Year-End Results

Written by Customer Service on March 24, 2023. Posted in Public Companies.

TORONTO, March 24, 2023 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) today announces its financial results for the fourth quarter and year ending December 31, 2022, and provides an update on the Company’s activities at the Valentine Gold Project (the “Project”) in the central region of Newfoundland and Labrador (“NL”). Fourth Quarter and Full-Year Financial Results (all figures are in Canadian dollars unless otherwise noted):Cash and cash equivalents at December 31, 2022 of $132.9 million; Capital Expenditures of $18.5 million and $74.6 million for the three and twelve months ended December 31, 2022, respectively, as the Company commenced construction activities at the Project; The Project’s cost-to-complete at October 31, 2022 was estimated at $463 million. Construction costs incurred...

Mexican Federal Economic Competition Commission Approves Pan American Silver’s Arrangement with Yamana and Agnico Eagle

Written by Customer Service on March 24, 2023. Posted in Mergers And Acquisitions.

Pan American Declares Dividend with Respect to the First Quarter of 2023 VANCOUVER, British Columbia, March 24, 2023 (GLOBE NEWSWIRE) — Pan American Silver Corp. (NASDAQ: PAAS) (TSX: PAAS) (“Pan American“) and Yamana Gold Inc. (TSX: YRI; NYSE: AUY; LSE: AUY) (“Yamana“) are pleased to provide an update on the status of Pan American’s proposed acquisition of all of the issued and outstanding common shares of Yamana, following the sale by Yamana of its Canadian assets, including certain subsidiaries and partnerships which hold Yamana’s interests in the Canadian Malartic mine, to Agnico Eagle Mines Limited, all by way of a plan of arrangement (the “Arrangement“) under the Canada Business Corporations Act. On March 23, 2023, the Mexican Federal Economic Competition Commission approved...

HONKARAKENNE’S BOARD OF DIRECTORS’ REPORT, FINANCIAL STATEMENTS, CORPORATE GOVERNANCE STATEMENT AND REMUNERATION REPORT FOR 2022 HAVE BEEN PUBLISHED

Written by Customer Service on March 24, 2023. Posted in Public Companies.

HONKARAKENNE OYJ Stock Exchange Release 24 March 2023 at 13:00 p.m. HONKARAKENNE’S BOARD OF DIRECTORS’ REPORT, FINANCIAL STATEMENTS, CORPORATE GOVERNANCE STATEMENT AND REMUNERATION REPORT FOR 2022 HAVE BEEN PUBLISHED Honkarakenne has published its Board of Directors’ Report, Financial Statements and the Auditor’s Report for year 2022. The Board of Director’s Report and Financial Statements as well as the European Single Electronic Format (ESEF) Financial Statements are attached to this release and also available on the company’s website https://investors.honka.com/en/investors/reports_and_presentations. The ESEF Financial Statements have not been certified by an auditor. In addition, Honkarakenne Oyj has published today the Corporate Governance Statement and Remuneration Report for the year 2022. The report on...

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living with mental health conditions Continued operational progress on robust clinical pipeline, with multiple phase 1 and phase 2 proof-of-concept datasets expected in the next two years $273 million in cash, cash equivalents and short-term investments at end of 2022 and access to a term loan facility of up to an additional $160 million provide anticipated runway into the first half of 2026NEW YORK and BERLIN, March 24, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported fourth quarter and full year 2022 financial results and provided clinical pipeline highlights. “With...

FirstFarms A/S rewards 2022 result

Written by Customer Service on March 24, 2023. Posted in Public Companies.

The entire management at domestic and foreign level is offered warrants and are thus, eventually, entitled to subscribe shares at a pre-agreed price. With the offer of warrants, FirstFarms’ Board of Directors wishes to reward the company’s management for a great effort, which among other things, has led to, that the company earlier today presented the 2022-accounts – the best since the stock exchange listing in 2006 and progress for 7th year in a row.A turnover of 418 mDKK An EBITDA of 147 mDKK An EBIT of 96 mDKK A pre-tax result of 84 mDKK”We have talented managers in the entire organisation, who has been able to secure a high efficiency in all branches of operation and on all locations, so we have increased earnings and fulfilled own demands to a continued growth. The goal is to become one of Europe’s best operated and most profitable...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals